Glucocorticoid-induced Osteoporosis
📧 Sign up to get email alerts when something new happens for Glucocorticoid-induced Osteoporosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-03-13FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for Teriparatide submitted by Prasco Laboratories. The approval updates the drug’s labeling and/…
-
FDA approval · 2013-02-25FDA Approved: ALENDRONATE SODIUM — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s generic alendronate sodium tablets under an original ANDA (ANDA 090520). The approval covers o…
-
FDA approval · 2013-02-15FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Teriparatide submitted by Prasco Laboratories, signaling regulatory approval related to a generi…
-
FDA approval · 2013-02-05FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic alendronate sodium product from Aurobindo Pharma Limited (ANDA 090124). The approval a…
-
FDA approval · 2012-08-13FDA Approved: ATELVIA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for ATELVIA (risedronate sodium) from Allergan.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-06-25FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for alendronate sodium supplied by Aurobindo Pharma Limited under ANDA090124.
-
FDA approval · 2012-05-22FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for alendronate sodium from Amneal Pharmaceuticals of New York LLC, indicating updated labeling or a…
-
FDA approval · 2012-05-16FDA Approved: ALENDRONATE — Supplemental Application (Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for ALENDRONATE SODIUM tablets from Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd., enabling a …
-
FDA approval · 2012-03-13FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for teriparatide submitted by Prasco Laboratories.
-
FDA approval · 2012-02-06FDA Approved: FOSAMAX — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Fosamax (alendronate sodium) from Organon LLC, updating the drug's labeling and/or approved …
-
FDA approval · 2011-08-22FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Actonel (risedronate sodium) by Allergan, Inc.
-
FDA approval · 2011-08-10FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for teriparatide filed by Prasco Laboratories, expanding the regulatory status of the product un…
-
FDA approval · 2011-07-07FDA Approved: ALENDRONATE SODIUM — Supplemental Application (EXELAN PHARMACEUTICALS INC.)
FDA approved a supplemental application for alendronate sodium submitted by Exelan Pharmaceuticals.
-
FDA approval · 2011-04-06FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ALENDRONATE SODIUM from Aurobindo Pharma Limited, indicating approval of a supplemental submissi…
-
FDA approval · 2011-04-01FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for alendronate sodium filed by Amneal Pharmaceuticals of New York LLC. This action updates the regu…
-
FDA approval · 2011-02-15FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Alendronate sodium filed by Aurobindo Pharma Limited.
-
FDA approval · 2010-08-24FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for alendronate sodium from Aurobindo Pharma Limited, enabling the marketing of a generic produc…
-
FDA approval · 2010-04-22FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for ALENDRONATE SODIUM submitted by Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2009-09-24FDA Approved: ALENDRONATE — Original Application (Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.)
FDA approved Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.'s generic alendronate (alendronate sodium tablets) via an Original Applicat…
-
FDA approval · 2009-07-23FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Actonel (risendronate sodium) from Allergan, Inc., approving changes to the product labeling und…
-
FDA approval · 2008-10-08FDA Approved: FOSAMAX — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for FOSAMAX (alendronate sodium) submitted by Organon LLC.
-
FDA approval · 2008-08-04FDA Approved: ALENDRONATE SODIUM — Original Application (EXELAN PHARMACEUTICALS INC.)
FDA approved the original application for alendronate sodium (Exelan Pharmaceuticals Inc.), making this generic osteoporosis therapy availab…
-
FDA approval · 2008-08-04FDA Approved: ALENDRONATE SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approves the original application for alendronate sodium from Aurobindo Pharma Limited as a generic therapy.
-
FDA approval · 2008-06-25FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for teriparatide submitted by Prasco Laboratories.
-
FDA approval · 2008-04-22FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Actonel (risedronate sodium) submitted by Allergan, Inc., resulting in an approved update to the…